Aljian Capital Management LLC purchased a new stake in Danaher Co. (NYSE:DHR - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,344 shares of the conglomerate's stock, valued at approximately $652,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Danaher during the second quarter worth $25,000. nVerses Capital LLC acquired a new position in shares of Danaher during the 2nd quarter valued at about $25,000. MFA Wealth Advisors LLC purchased a new stake in shares of Danaher in the second quarter valued at about $51,000. Financial Connections Group Inc. acquired a new stake in Danaher during the second quarter worth about $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in Danaher in the 1st quarter valued at about $55,000. Hedge funds and other institutional investors own 79.05% of the company's stock.
Wall Street Analyst Weigh In
DHR has been the subject of several analyst reports. Leerink Partners increased their price objective on Danaher from $275.00 to $280.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 24th. Raymond James decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Wells Fargo & Company started coverage on Danaher in a research note on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price target on the stock. Royal Bank of Canada decreased their price target on shares of Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Finally, Barclays cut their price objective on Danaher from $285.00 to $275.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $287.16.
View Our Latest Stock Report on Danaher
Insider Activity at Danaher
In other Danaher news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company's stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.
Danaher Trading Down 0.4 %
Danaher stock traded down $1.00 during trading on Monday, reaching $229.50. The company had a trading volume of 3,932,732 shares, compared to its average volume of 2,764,637. Danaher Co. has a 12-month low of $207.63 and a 12-month high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock's 50 day moving average price is $261.33 and its two-hundred day moving average price is $260.45. The firm has a market capitalization of $165.76 billion, a price-to-earnings ratio of 43.80, a PEG ratio of 4.24 and a beta of 0.85.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm posted $2.02 EPS. As a group, equities analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date was Friday, September 27th. Danaher's dividend payout ratio (DPR) is presently 20.61%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.